700
Registro EXTINTO, com base na norma legal indicada.
INCISO I DO ART. 142 DA LPI.
RPI 1820
11/22/2005
Back to search
Official data from INPI
MULTILEUKIN
This trademark appears in the official INPI history.
Even when the status is closed, the history helps calibrate risk, avoid repeating mistakes, and define a safe naming strategy.
Registro ExtintoType: WordOffice: Brazil
Quick snapshot
MULTILEUKIN
ST13
BR500000817301429Class
5
Filing
817301429
Registration
817301429
Progress at the INPI
- Filing05/26/93
- Publication
- Examination
- Allowance05/24/94
- Grant12/13/94
- Terminated11/22/05
The registration was granted on 12/13/1994 and later terminated. The mark is no longer protected.
Check whether this name is availableLatest action published by the INPI: 11/22/2005. We update with every new RPI gazette, published weekly.
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
INPI status
Registro Extinto
Case type
Application and registration
Recorded events
5
Latest update
11/22/2005
Trademark type
Word
Nice classes
5
Filing date
05/26/1993
Registration date
12/13/1994
Expiration date
12/13/2004
Complete case details
Structured fields from the responsible authority and the official record.
Nature
De Produto
Responsible office
Brazil
Owner type
NÃO RESIDENTE
Owner location
CH
Holders and representatives
Holders
NOVARTIS AG.
Representatives
M. A. (pessoa física)
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medicamentos que atuam sobre o sangue e os órgãos hematopoiéticos
Publications
History of INPI decisions and trademark events.
5 publications found
565
ANOTADA A TRANSFERENCIA.
CED. SANDOZ AG (SANDOZ S.A , SANDOZ LTD.)
RPI 1487
07/06/1999
400
Comunicacao de CONCESSAO DE REGISTRO, fixando-se a data desta RPI para o INICIO DE SUA VIGENCIA. O Certificado de Registro estara a disposicao do Titular na recepcao da Diretoria de Marcas, apos 60 (sessenta) dias a contar desta data. Podera, a pedido, ser remetido a qualquer Delegacia e/ou Representacao do INPI/MICT.
*INT. DANNEMANN, SIEMSEN, BIGLER
RPI 1254
12/13/1994
350
DEFERIDO o pedido de registro, com base no Art. 64 do CPI.
* INT. DANEMANN
RPI 1225
05/24/1994
300
Reconhecida a VIABILIDADE do pedido de registro, de acordo com o paragrafo 4o. do Art. 79 do CPI.
INT. DANNEMANN
RPI 1195
10/26/1993
NOVARTIS AG. also protects technology and design at the INPI
20 patent applications under the same owner.
Patents
COMPOSIÇÕES DE PROTEÍNA RSV F E MÉTODOS PARA FAZER AS MESMASBISFOSFOFATOS PARA O TRATAMENTO DE ATEROSCLEROSE E DISPOSITIV...DERIVADOS DE PIPERIDINA COMO INIBIDORES DE CCR5DERIVADOS DE AMINO PROPANOLCOMBINAÇÃO COMPREENDENDO UM AGENTE DE ALQUILAÇÃO E UM AGENTE ...N-SULFONILAMINOACETONITRILAS TENDO PROPRIEDADES PESTICIDAS
Continuous trademark protection
Get notified about every new filing that threatens MULTILEUKIN or your mark.
Professional 24-month watch service: we monitor INPI for you and alert you in time to oppose — before conflicts become losses.